X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Unichem Lab with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   TEVA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
TEVA PHARMA
Dec-13
UNICHEM LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3822,929-   
Low Rs2342,545-   
Sales per share (Unadj.) Rs116.31,681.2-  
Earnings per share (Unadj.) Rs-18.9105.0-  
Cash flow per share (Unadj.) Rs-11.7240.9-  
Dividends per share (Unadj.) Rs5.0091.94-  
Dividend yield (eoy) %1.63.4 48.3%  
Book value per share (Unadj.) Rs381.01,867.5-  
Shares outstanding (eoy) m70.34848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.6 162.7%   
Avg P/E ratio x-16.326.1 -62.5%  
P/CF ratio (eoy) x-26.211.4 -231.0%  
Price / Book Value ratio x0.81.5 55.2%  
Dividend payout %-26.487.5 -30.2%   
Avg Mkt Cap Rs m21,6682,320,993 0.9%   
No. of employees `0002.344.9 5.1%   
Total wages/salary Rs m2,0060-   
Avg. sales/employee Rs Th3,587.831,719.6 11.3%   
Avg. wages/employee Rs Th880.00-   
Avg. net profit/employee Rs Th-583.71,981.5 -29.5%   
INCOME DATA
Net Sales Rs m8,1801,425,637 0.6%  
Other income Rs m6100-   
Total revenues Rs m8,7901,425,637 0.6%   
Gross profit Rs m-1,320390,411 -0.3%  
Depreciation Rs m505115,236 0.4%   
Interest Rs m8028,002 0.3%   
Profit before tax Rs m-1,295247,174 -0.5%   
Minority Interest Rs m01,123 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-162,256 0.0%   
Tax Rs m33-3,018 -1.1%   
Profit after tax Rs m-1,33189,058 -1.5%  
Gross profit margin %-16.127.4 -58.9%  
Effective tax rate %-2.6-1.2 211.3%   
Net profit margin %-16.36.2 -260.5%  
BALANCE SHEET DATA
Current assets Rs m23,318962,870 2.4%   
Current liabilities Rs m4,635839,704 0.6%   
Net working cap to sales %228.48.6 2,643.6%  
Current ratio x5.01.1 438.7%  
Inventory Days Days12291 134.1%  
Debtors Days Days12196 126.6%  
Net fixed assets Rs m8,163465,644 1.8%   
Share capital Rs m1413,509 4.0%   
"Free" reserves Rs m26,6600-   
Net worth Rs m26,8011,583,612 1.7%   
Long term debt Rs m3728,960 0.0%   
Total assets Rs m31,8903,258,036 1.0%  
Interest coverage x-15.29.8 -154.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.30.4 58.6%   
Return on assets %-3.93.6 -109.2%  
Return on equity %-5.05.6 -88.3%  
Return on capital %-4.54.9 -92.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m4,3560-   
CASH FLOW
From Operations Rs m-1,123227,173 -0.5%  
From Investments Rs m16,487-80,496 -20.5%  
From Financial Activity Rs m-8,811-272,509 3.2%  
Net Cashflow Rs m6,552-125,833 -5.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.18 Rs / USD

Compare UNICHEM LAB With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare UNICHEM LAB With: SHASUN PHARMA  NATCO PHARMA  GSK PHARMA  PFIZER  TTK HEALTHCARE  



Today's Market

Nifty Hits Fresh Record High; Sensex Up Over 330 Points(12:30 pm)

After opening the day on a positive note, stock markets in India continued their momentum and went on to scale their record-high levels.

Related Views On News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1% (Quarterly Result Update)

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 20, 2018 03:37 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS